Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable doses of
surface-controlled water dispersible curcumin (curcumin) that can be given to patients with
advanced cancer. The safety of this drug will also be studied.